Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7862988 | 0.84 | — | — | |
| Urea SCHEMBL28520912 | 0.78 | TDP1 (0.46) | TDP1ALDH1A1FFAR3HSD17B10 | |
| SCHEMBL12969713 | 0.78 | TDP1 (0.30) | TDP1ALDH1A1FFAR3 | |
| SCHEMBL107405 | 0.76 | — | — | |
| SCHEMBL17865 | 0.76 | — | — | |
| SCHEMBL156659 | 0.76 | FFAR3 (0.47) | TDP1ALDH1A1FFAR3TSHRHSD17B10 | |
| SCHEMBL3332190 | 0.76 | — | — | |
| SCHEMBL9517162 | 0.76 | — | — | |
| SCHEMBL4332526 | 0.76 | — | — | |
| SCHEMBL11869323 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRHSD17B10SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097044-A1 | AEROGEL IMPLANTS FOR CONTRACEPTION | Contraline, Inc. (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250134702-A1 | AEROGEL IMPLANTS FOR CONTRACEPTION | CONTRALINE INC (US) | 2025-05-01 | — | — | US | claimed |
| CN-118338782-A | Biocidal compositions | 巴斯夫欧洲公司 | 2024-07-12 | — | — | CN | claimed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | claimed |
| WO-2001068726-A1 | ATOM TRANSFER RADICAL POLYMERISATION CATALYST | BP CHEMICALS LIMITED (GB) | 2001-09-20 | — | — | WO | claimed |
| EP-0370547-B1 | Graft stabilising and prestabilising copolymers, their preparation, process to obtain polymer-polyol dispersions and process to obtain polyurethane foams | NEW CARBOCHIM SA (BE) | 1994-03-16 | — | — | EP | claimed |
| US-4555359-A | FROM TRIMETHYLCYCLOPENTANONE; PERFUMES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1985-11-26 | — | — | US | claimed |
| JP-4234338-A | — | — | None | — | — | JP | disclosed |
| US-12630751-B2 | Two stage methods for processing adhesives and related compositions | AVERY DENNISON CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| EP-3898810-B1 | ADHESIVE WITH HIGH FILLER CONTENT | AVERY DENNISON CORP (US) | 2025-12-03 | — | — | EP | disclosed |
| US-12312518-B2 | Adhesive with high filler content | AVERY DENNISON CORPORATION (US) | 2025-05-27 | — | — | US | disclosed |
| US-12304988-B2 | Acrylic polymers having controlled placement of functional groups | AVERY DENNISON CORPORATION (US) | 2025-05-20 | — | — | US | disclosed |
| WO-2025097044-A1 | AEROGEL IMPLANTS FOR CONTRACEPTION | Contraline, Inc. (US) | 2025-05-08 | — | — | WO | disclosed |
| US-4216322-A | Process for making triethylene diamines | THE UPJOHN COMPANY (US) | 1980-08-05 | — | — | US | disclosed |
| US-4148988-A | DENTAL ADHESIVE AND UNDERVOATING FOR PAINTS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1979-04-10 | — | — | US | disclosed |
| US-4127508-A | FOR THE HYDROGENATION OF UNSATURATED CARBONYLS TO ALCOHOLS | CELANESE CORPORATION (US) | 1978-11-28 | — | — | US | disclosed |
| US-4100087-A | Pressure-fixing magnetic developer containing hydrogenated polystyrene binder for electrostatic photography and process for preparation thereof | MITA INDUSTRIAL CO. LTD. (JP) | 1978-07-11 | — | — | US | disclosed |
| US-4096193-A | SILVER-CADMIUM CATALYST | CELANESE CORPORATION (US) | 1978-06-20 | — | — | US | disclosed |
| US-4072727-A | Silver-cadmium-zinc alloy catalyst for hydrogenation of acrolein to allyl alcohol | CELANESE CORPORATION (US) | 1978-02-07 | — | — | US | disclosed |
| US-4066630-A | END CAPPED POLYALKYLENE CARBONATES HAVING IMPROVED THERMAL STABILITY | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1978-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630751-B2 | Two stage methods for processing adhesives and related compositions | CDH1, ITGB2, ITGA2B | TDP1 1088/4885ALDH1A1 2071/4885FFAR3 3205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.